Marc S Zimmer
Examiner (ID: 11482, Phone: (571)272-1096 , Office: P/1765 )
Most Active Art Unit | 1765 |
Art Unit(s) | 1765, 1796, 1712 |
Total Applications | 2564 |
Issued Applications | 2008 |
Pending Applications | 117 |
Abandoned Applications | 439 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9944330
[patent_doc_number] => 08993631
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-31
[patent_title] => 'Method of treating contrast-induced nephropathy'
[patent_app_type] => utility
[patent_app_number] => 13/294295
[patent_app_country] => US
[patent_app_date] => 2011-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76467
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13294295
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/294295 | Method of treating contrast-induced nephropathy | Nov 10, 2011 | Issued |
Array
(
[id] => 8186915
[patent_doc_number] => 20120115939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'METHODS FOR USING LIPOIC ACID'
[patent_app_type] => utility
[patent_app_number] => 13/292525
[patent_app_country] => US
[patent_app_date] => 2011-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5214
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115939.pdf
[firstpage_image] =>[orig_patent_app_number] => 13292525
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/292525 | METHODS FOR USING LIPOIC ACID | Nov 8, 2011 | Abandoned |
Array
(
[id] => 9161080
[patent_doc_number] => 20130309357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'PET FOOD PREPARATIONS CONTAINING PROBIOTIC MICRO-ORGANISMS'
[patent_app_type] => utility
[patent_app_number] => 13/881492
[patent_app_country] => US
[patent_app_date] => 2011-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9489
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881492
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/881492 | PET FOOD PREPARATIONS CONTAINING PROBIOTIC MICRO-ORGANISMS | Nov 1, 2011 | Abandoned |
Array
(
[id] => 9710857
[patent_doc_number] => 08835425
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => 'Use of selective GABA A α5 negative allosteric modulators for the treatment of central nervous system conditions'
[patent_app_type] => utility
[patent_app_number] => 13/286240
[patent_app_country] => US
[patent_app_date] => 2011-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 21106
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13286240
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/286240 | Use of selective GABA A α5 negative allosteric modulators for the treatment of central nervous system conditions | Oct 31, 2011 | Issued |
Array
(
[id] => 8405488
[patent_doc_number] => 20120237551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-20
[patent_title] => 'IMMUNE RESPONSE MODIFIER FORMULATIONS CONTAINING OLEIC ACID AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/279696
[patent_app_country] => US
[patent_app_date] => 2011-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7233
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13279696
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/279696 | Immune response modifier formulations containing oleic acid and methods | Oct 23, 2011 | Issued |
Array
(
[id] => 9004478
[patent_doc_number] => 20130225603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'MDM2 INHIBITORS FOR TREATMENT OF OCULAR CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/876408
[patent_app_country] => US
[patent_app_date] => 2011-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 22802
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876408
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/876408 | MDM2 INHIBITORS FOR TREATMENT OF OCULAR CONDITIONS | Sep 25, 2011 | Abandoned |
Array
(
[id] => 7720944
[patent_doc_number] => 20120010279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'COMPOSITION COMPRISING (-)-DELTA9-TRANS-TETRAHYDROCANNABINOL'
[patent_app_type] => utility
[patent_app_number] => 13/237388
[patent_app_country] => US
[patent_app_date] => 2011-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3417
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20120010279.pdf
[firstpage_image] =>[orig_patent_app_number] => 13237388
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/237388 | COMPOSITION COMPRISING (-)-DELTA9-TRANS-TETRAHYDROCANNABINOL | Sep 19, 2011 | Abandoned |
Array
(
[id] => 8313682
[patent_doc_number] => 20120190702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'USE OF METHYLNALTREXONE AND RELATED COMPOUNDS TO TREAT CONSTIPATION IN CHRONIC OPIOID USERS'
[patent_app_type] => utility
[patent_app_number] => 13/230193
[patent_app_country] => US
[patent_app_date] => 2011-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8352
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13230193
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/230193 | USE OF METHYLNALTREXONE AND RELATED COMPOUNDS TO TREAT CONSTIPATION IN CHRONIC OPIOID USERS | Sep 11, 2011 | Abandoned |
Array
(
[id] => 7791643
[patent_doc_number] => 20120053199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'NOSCAPINE AND ANALOGS AND METHODS RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 13/216458
[patent_app_country] => US
[patent_app_date] => 2011-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15082
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20120053199.pdf
[firstpage_image] =>[orig_patent_app_number] => 13216458
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/216458 | Noscapine and analogs and methods related thereto | Aug 23, 2011 | Issued |
Array
(
[id] => 7663659
[patent_doc_number] => 20110312928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'Progesterone Containing Oral Dosage Forms and Related Methods'
[patent_app_type] => utility
[patent_app_number] => 13/204562
[patent_app_country] => US
[patent_app_date] => 2011-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16395
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312928.pdf
[firstpage_image] =>[orig_patent_app_number] => 13204562
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/204562 | Progesterone Containing Oral Dosage Forms and Related Methods | Aug 4, 2011 | Abandoned |
Array
(
[id] => 7567474
[patent_doc_number] => 20110287537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'NEUROPROTECTIVE AGENTS FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/195626
[patent_app_country] => US
[patent_app_date] => 2011-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12323
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20110287537.pdf
[firstpage_image] =>[orig_patent_app_number] => 13195626
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/195626 | Neuroprotective agents for the prevention and treatment of neurodegenerative diseases | Jul 31, 2011 | Issued |
Array
(
[id] => 10095841
[patent_doc_number] => 09132136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-15
[patent_title] => 'Pharmaceutical combination'
[patent_app_type] => utility
[patent_app_number] => 13/189600
[patent_app_country] => US
[patent_app_date] => 2011-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 25
[patent_no_of_words] => 15941
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13189600
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/189600 | Pharmaceutical combination | Jul 24, 2011 | Issued |
Array
(
[id] => 8363263
[patent_doc_number] => 08252327
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-28
[patent_title] => 'Oral controlled release dosage form'
[patent_app_type] => utility
[patent_app_number] => 13/179830
[patent_app_country] => US
[patent_app_date] => 2011-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6029
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 360
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13179830
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/179830 | Oral controlled release dosage form | Jul 10, 2011 | Issued |
Array
(
[id] => 7720894
[patent_doc_number] => 20120010229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'THERAPEUTIC REGIMENS FOR HEDGEHOG-ASSOCIATED CANCERS'
[patent_app_type] => utility
[patent_app_number] => 13/179404
[patent_app_country] => US
[patent_app_date] => 2011-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 42158
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20120010229.pdf
[firstpage_image] =>[orig_patent_app_number] => 13179404
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/179404 | THERAPEUTIC REGIMENS FOR HEDGEHOG-ASSOCIATED CANCERS | Jul 7, 2011 | Abandoned |
Array
(
[id] => 8822320
[patent_doc_number] => 20130123365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'USE OF FTS AND ANALOGS TO TREAT NON-AUTOIMMUNE-ALLERGIC AND NON-ALLERGIC INFLAMMATORY CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/809044
[patent_app_country] => US
[patent_app_date] => 2011-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5920
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809044
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/809044 | USE OF FTS AND ANALOGS TO TREAT NON-AUTOIMMUNE-ALLERGIC AND NON-ALLERGIC INFLAMMATORY CONDITIONS | Jul 6, 2011 | Abandoned |
Array
(
[id] => 7670185
[patent_doc_number] => 20110319454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'DERIVATIVES OF CYCLOALKYL- AND CYCLOALKENYL-1,2-DICARBOXYLIC ACID COMPOUNDS HAVING FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) AGONIST OR ANTAGONIST ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/168464
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16437
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13168464
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/168464 | Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity | Jun 23, 2011 | Issued |
Array
(
[id] => 7744528
[patent_doc_number] => 20120022095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'TOPICAL RAPAMYCIN FOR TREATMENT OF FACIAL ANGIOFIBROMAS IN TUBEROUS SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/168634
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2242
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022095.pdf
[firstpage_image] =>[orig_patent_app_number] => 13168634
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/168634 | TOPICAL RAPAMYCIN FOR TREATMENT OF FACIAL ANGIOFIBROMAS IN TUBEROUS SCLEROSIS | Jun 23, 2011 | Abandoned |
Array
(
[id] => 7744414
[patent_doc_number] => 20120022051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'RAPID ONSET LIQUID MIDAZOLAM COMPOSITION FOR BUCCAL ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 13/164922
[patent_app_country] => US
[patent_app_date] => 2011-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6685
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022051.pdf
[firstpage_image] =>[orig_patent_app_number] => 13164922
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/164922 | Rapid onset liquid midazolam composition for buccal administration | Jun 20, 2011 | Issued |
Array
(
[id] => 7663717
[patent_doc_number] => 20110312986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'Composition and Method for Treating Overactive Bladder'
[patent_app_type] => utility
[patent_app_number] => 13/162424
[patent_app_country] => US
[patent_app_date] => 2011-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10670
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312986.pdf
[firstpage_image] =>[orig_patent_app_number] => 13162424
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/162424 | Composition and Method for Treating Overactive Bladder | Jun 15, 2011 | Abandoned |
Array
(
[id] => 6091696
[patent_doc_number] => 20110218515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'Methods for Treating Acute Myocardial Infarctions and Associated Disorders'
[patent_app_type] => utility
[patent_app_number] => 13/115697
[patent_app_country] => US
[patent_app_date] => 2011-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 24116
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20110218515.pdf
[firstpage_image] =>[orig_patent_app_number] => 13115697
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/115697 | Methods for Treating Acute Myocardial Infarctions and Associated Disorders | May 24, 2011 | Abandoned |